STAT3 and Hepatic fibrosis: Our study showed, for the first time, the inhibitory effects of C8G from R. palmatum on HSC activation through inhibition of the STAT3 pathway, which is a key therapeutic target in hepatic fibrosis, thus providing experimental evidence for the hepatoprotective effects of C8G against liver damage.